Back to Search
Start Over
Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy
- Source :
- BMC Public Health, Vol 11, Iss 1, p 400 (2011), BMC Public Health, BMC Public Health, BioMed Central, 2011, 11 (1), pp.400. 〈10.1186/1471-2458-11-400〉, BMC Public Health, 2011, 11 (1), pp.400. ⟨10.1186/1471-2458-11-400⟩, BMC Public Health, BioMed Central, 2011, 11 (1), pp.400. ⟨10.1186/1471-2458-11-400⟩
- Publication Year :
- 2011
- Publisher :
- BMC, 2011.
-
Abstract
- Background Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines. Methods A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively. Results A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed. Conclusions A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions.
- Subjects :
- Male
medicine.medical_specialty
media_common.quotation_subject
Human immunodeficiency virus (HIV)
Psychological intervention
Public policy
Prison
HIV Infections
Public Policy
medicine.disease_cause
Health Services Accessibility
03 medical and health sciences
0302 clinical medicine
Environmental health
Surveys and Questionnaires
Epidemiology
Overpopulation
mental disorders
medicine
Humans
030212 general & internal medicine
media_common
business.industry
Public health
lcsh:Public aspects of medicine
Public Health, Environmental and Occupational Health
virus diseases
[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie
lcsh:RA1-1270
social sciences
3. Good health
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
Family medicine
Prisons
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Female
France
Public Health
Biostatistics
business
030217 neurology & neurosurgery
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 14712458
- Volume :
- 11
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- BMC Public Health
- Accession number :
- edsair.doi.dedup.....f7493b2f1f55b5b48712426e947c4f75
- Full Text :
- https://doi.org/10.1186/1471-2458-11-400〉